These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 7962652)

  • 1. Pathology of endometrium treated with tamoxifen.
    Ismail SM
    J Clin Pathol; 1994 Sep; 47(9):827-33. PubMed ID: 7962652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Factors Associated with Endometrial Pathology in Premenopausal Breast Cancer Patients Treated with Tamoxifen.
    Lee M; Piao J; Jeon MJ
    Yonsei Med J; 2020 Apr; 61(4):317-322. PubMed ID: 32233174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometrial thickness in tamoxifen-treated patients: correlation with clinical and pathologic findings.
    Hann LE; Giess CS; Bach AM; Tao Y; Baum HJ; Barakat RR
    AJR Am J Roentgenol; 1997 Mar; 168(3):657-61. PubMed ID: 9057510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound.
    Gerber B; Krause A; Müller H; Reimer T; Külz T; Makovitzky J; Kundt G; Friese K
    J Clin Oncol; 2000 Oct; 18(20):3464-70. PubMed ID: 11032586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sonohysterography compared with endometrial biopsy for evaluation of the endometrium in tamoxifen-treated women.
    Hann LE; Kim CM; Gonen M; Barakat R; Choi PH; Bach AM
    J Ultrasound Med; 2003 Nov; 22(11):1173-9. PubMed ID: 14620887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer.
    Deligdisch L; Kalir T; Cohen CJ; de Latour M; Le Bouedec G; Penault-Llorca F
    Gynecol Oncol; 2000 Aug; 78(2):181-6. PubMed ID: 10926800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with endometrial pathology during tamoxifen therapy in women with breast cancer: a retrospective analysis of 821 biopsies.
    Jeon J; Kim SE; Lee DY; Choi D
    Breast Cancer Res Treat; 2020 Jan; 179(1):125-130. PubMed ID: 31541382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sonohysterography for evaluation of the endometrium in women treated with tamoxifen.
    Hann LE; Gretz EM; Bach AM; Francis SM
    AJR Am J Roentgenol; 2001 Aug; 177(2):337-42. PubMed ID: 11461858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen and the endometrium: review of 102 cases and comparison with HRT-related and non-HRT-related endometrial pathology.
    Kennedy MM; Baigrie CF; Manek S
    Int J Gynecol Pathol; 1999 Apr; 18(2):130-7. PubMed ID: 10202670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of tamoxifen on the uterus.
    Ismail SM
    Curr Opin Obstet Gynecol; 1996 Feb; 8(1):27-31. PubMed ID: 8777254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of endometrial proliferation in pipelle biopsies in tamoxifen-treated postmenopausal women with breast cancer in Kuwait.
    Al-Azemi M; Labib NS; Motawy MM; Temmim L; Moussa MA; Omu AE
    Med Princ Pract; 2004; 13(1):30-4. PubMed ID: 14657616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tamoxifen and endometrial pathology].
    Negoiţă M; Terinte C; Mihailovici MS
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1114-7. PubMed ID: 21500468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of tamoxifen on the endometrium.
    Uziely B; Lewin A; Brufman G; Dorembus D; Mor-Yosef S
    Breast Cancer Res Treat; 1993; 26(1):101-5. PubMed ID: 8400318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy].
    Hauth E; Libera H; Kimmig R; Forsting M
    Rofo; 2006 Mar; 178(3):316-23. PubMed ID: 16508840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine side effects of tamoxifen: a need for systematic pretreatment screening.
    Berlière M; Charles A; Galant C; Donnez J
    Obstet Gynecol; 1998 Jan; 91(1):40-4. PubMed ID: 9464718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of endometrium during tamoxifen therapy of breast cancer].
    Obrebowska A; Sibila-Owczarska A; Sajdak S
    Ginekol Pol; 2002 Nov; 73(11):1109-12. PubMed ID: 12722407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmenopausal endometrial pathologies with tamoxifen treatment: comparison between hysteroscopic and hysterectomy findings.
    Cohen I; Azaria R; Aviram R; Bernheim J; Tepper R; Cordoba M; Beyth Y
    Gynecol Obstet Invest; 1999; 48(3):187-92. PubMed ID: 10545744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen.
    Lahti E; Blanco G; Kauppila A; Apaja-Sarkkinen M; Taskinen PJ; Laatikainen T
    Obstet Gynecol; 1993 May; 81(5 ( Pt 1)):660-4. PubMed ID: 8469450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of endometrial pathologies collected by hysteroscopy and hysterectomy in postmenopausal breast cancer tamoxifen-treated patients.
    Cohen I; Azaria R; Bernheim J; Tepper R; Sharony R; Beyth Y
    Eur J Gynaecol Oncol; 2000; 21(4):418-22. PubMed ID: 11055500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial disorders in 406 breast cancer patients on tamoxifen: the case for less intensive monitoring.
    Vosse M; Renard F; Coibion M; Neven P; Nogaret JM; Hertens D
    Eur J Obstet Gynecol Reprod Biol; 2002 Feb; 101(1):58-63. PubMed ID: 11803101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.